» Articles » PMID: 17134630

Non-high-density Lipoprotein and Very-low-density Lipoprotein Cholesterol and Their Risk Predictive Values in Coronary Heart Disease

Overview
Journal Am J Cardiol
Date 2006 Dec 1
PMID 17134630
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

To determine if non-high-density lipoprotein (HDL) cholesterol is a more useful predictor of coronary heart disease (CHD) risk than low-density lipoprotein (LDL) cholesterol and if very-low-density lipoprotein (VLDL) cholesterol is an independent predictor of CHD risk, data from the Framingham Heart Study (2,693 men, 3,101 women) were used for this analysis. All subjects were aged > or =30 years and free of CHD at baseline, and incident CHD was the end point (618 men, 372 women). Cox proportional-hazards models were used to assess the risk for CHD (relative risks and 95% confidence intervals) on the basis of the joint distribution of LDL cholesterol and non-HDL cholesterol (in milligrams per deciliter), as well as LDL cholesterol, non-HDL cholesterol, and VLDL cholesterol as continuous variables. After multivariate adjustment, within non-HDL cholesterol level, no association was found between LDL cholesterol and the risk for CHD, whereas within LDL cholesterol levels, a strong positive and graded association between non-HDL cholesterol and risk for CHD was observed. When the analysis was repeated within triglyceride levels (<200 vs > or =200 mg/dl), the risk pattern did not change significantly. Also, VLDL cholesterol was found to be a significant predictor of CHD risk after adjusting for LDL cholesterol at triglyceride levels of > or =200 or <200 mg/dl. In conclusion, these results suggest that non-HDL cholesterol level is a stronger predictor of CHD risk than LDL cholesterol; that is, VLDL cholesterol may play a critical role in the development of CHD.

Citing Articles

Antiseizure medications and their differing effects on cardiovascular risk.

Abbasi A, Abbasi B, Mintzer S, LoPinto-Khoury C Epilepsy Behav Rep. 2025; 29:100746.

PMID: 40007616 PMC: 11850784. DOI: 10.1016/j.ebr.2025.100746.


Examination of Lipoprotein and Lipid Levels of Adult Patients With Atherosclerosis, Myocardial Infarction, and Stroke: A Narrative Review.

Dushenko N, Vysochyn M Cureus. 2024; 16(10):e71239.

PMID: 39525216 PMC: 11550404. DOI: 10.7759/cureus.71239.


Impact of non-traditional lipid profiles on 1-year vascular outcomes in ischemic stroke patients with prior statin therapy and LDL-C < 100 mg/dL.

Kim H, Kim J, Lee J, Kim B, Kang J, Lee K Sci Rep. 2024; 14(1):22794.

PMID: 39354143 PMC: 11448496. DOI: 10.1038/s41598-024-73851-5.


Longitudinal associations of an exposome score with serum metabolites from childhood to adolescence.

Healy D, Zarei I, Mikkonen S, Soininen S, Viitasalo A, Haapala E Commun Biol. 2024; 7(1):890.

PMID: 39039257 PMC: 11263428. DOI: 10.1038/s42003-024-06146-0.


Discordance Between Very Low-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort.

Seehusen K, Remaley A, Sampson M, Meeusen J, Larson N, Decker P J Am Heart Assoc. 2024; 13(8):e031878.

PMID: 38591325 PMC: 11262497. DOI: 10.1161/JAHA.123.031878.